Business · 23/09/1997
FDA Releases Guidance on Reducing CJD Transmission via Blood and Blood Products
The Food and Drug Administration (FDA) has released a guidance document outlining revised precautions to minimize the risk of Creutzfeldt-Jakob Disease (CJD) transmission through blood and blood products, dated December 11, 1996, aimed at the blood industry and other interested parties.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →